SynergyMed has developed a cure for cancer that takes just ten minutes to administer.
This non-surgical solution has destroyed cancerous tumors in mice and dogs, and did so without damaging surrounding healthy tissue, causing cosmetic deformities, or affecting the subject’s quality of life. Now the company has its sights set on destroying similar tumors in humans.
SynergyMed has signed Letters of Intent (LOIs) from Boston Scientific and Medtronic and projects to generate $500 million in revenue within the next five years.
It will continue to run clinical studies treating tumors in dogs, and aims to start generating sales of its veterinary device later this year.